New HIV drug shows 'unprecedented' results: study, page
privacy
Pages:
ATS Members have flagged this thread 0 times
ATS Members have flagged this thread 0 times
Topic started on 14-4-2007 @ 01:35 PM by FredT
A new type of drug has shown promising results in HIV patients that have failed to respond to conventional treatment according to a new study. This
new type of medication called an "integrase inhibitor". Integrase inhibitors are the first type of drug that targets the three emzymes needed by the
HIV virus to replicate. In the 24 week study 65% of the 178 patients had dropped below the measurable threshold of HIV.
The long term effects fo the drug are still being studied, but if the side effects are minimal, this could be another stepping stone towards a vaccine or even cure for the disease.
The long term effects fo the drug are still being studied, but if the side effects are minimal, this could be another stepping stone towards a vaccine or even cure for the disease.
PARIS (AFP) - A new category of drug has shown promising results for HIV/AIDS patients who failed to respond to other treatments, a study to be published Saturday shows.
Especially when combined with other medications, raltegravir -- the first in a new class of anti-retroviral drugs called integrase inhibitors -- dramatically reduced the presence of the HIV virus and boosted immunity in clinical-trial patients, according to the study in the British journal The Lancet.
New HIV drug shows 'unprecedented' results: study
Pages: ^^TOP^^
Conclusive Evidence That "ALL" Vaccines Are Very Harmful Even Causing Death
Posted 15 days ago with 57 member flags
Posted 15 days ago with 57 member flags
5 Mainstream Diseases Respond to this drug ! - Breakthrough!
Posted 17 days ago with 14 member flags
Posted 17 days ago with 14 member flags
Making a Killing: The Untold Story of Psychotropic Drugging - Full Movie
Posted 11 days ago with 10 member flags
Posted 11 days ago with 10 member flags
The Above Top Secret Web sites are a
wholly owned social content community of
The Above Network, LLC.
This content community relies on
user-generated content from our member contributors.
The opinions of our members are not those of site ownership
who maintains strict editorial agnosticism and simply provides
a collaborative venue for free expression.
ATS Server: www3.theabovenetwork.com
Header data: 0.002 seconds
Page processed in: 0.023 seconds
wholly owned social content community of
The Above Network, LLC.
This content community relies on
user-generated content from our member contributors.
The opinions of our members are not those of site ownership
who maintains strict editorial agnosticism and simply provides
a collaborative venue for free expression.
ATS Server: www3.theabovenetwork.com
Header data: 0.002 seconds
Page processed in: 0.023 seconds
